Latest profit margin for Fischer Medical Ventures: 4.31% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2026
Trailing 12 months ending Sep 2026
Fischer Medical Ventures (FISCHER.NS) currently reports a profit margin of 4.31% as of September 2026. That compares with 11.67% in the prior-year period — down 63.1% year over year. That is below the sector sector average of 12.13%. Use the charts on this page to explore Fischer Medical Ventures's profit margin history and peer comparisons.
Fischer Medical Ventures's profit margin decreased from 11.67% to 4.31% — a 63.1% year-over-year decrease (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Fischer Medical Ventures's profit margin of 4.31% is lower than the its sector sector average of 12.13%. That is roughly 64.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Fischer Medical Ventures's current 4.31% should be judged against industry norms (sector average: 12.13%) and against FISCHER.NS's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of 4.31%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 12.13%. From there, open related valuation or income-statement pages for Fischer Medical Ventures, and consider following FISCHER.NS for alerts when major investors trade the stock.